From: The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in Kenya
Comparison Groups | PCS AUC | MCS AUC | SF6D AUC |
---|---|---|---|
CD4 < 200 vs CD4 ≥ 200 | 0.61 | 0.61 | 0.61 |
Viral Load ≤55,000 vs >55,000 | 0.56 | 0.54 | 0.57 |
WHO stage 1 vs stage 2 | 0.55 | 0.58 | 0.55 |
WHO stage 1 vs stage 3 | 0.67 | 0.67 | 0.64 |
WHO stage 1 vs stage 4 | 0.72 | 0.71 | 0.68 |